Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evommune (EVMN) Return on Equity (2025)

Evommune (EVMN) has disclosed Return on Equity for 1 consecutive years, with 6.9% as the latest value for Q4 2025.

  • Quarterly Return on Equity changed N/A to 6.9% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.9% through Dec 2025, changed N/A year-over-year, with the annual reading at 2.54% for FY2025, N/A changed from the prior year.
  • Return on Equity for Q4 2025 was 6.9% at Evommune.
  • The five-year high for Return on Equity was 6.9% in Q4 2025, with the low at 6.9% in Q4 2025.